Cargando…
Early detection of urothelial premalignant lesions using hexaminolevulinate fluorescence cystoscopy in high risk patients
BACKGROUND: To evaluate fluorescence cystoscopy with hexaminolevulinate (HAL) in the early detection of dysplasia (DYS) and carcinoma in situ (CIS) in select high risk patients. METHODS: We selected 30 consecutive bladder cancer patients at high risk for progression. After endoscopic resection, all...
Autores principales: | Blanco, Salvatore, Raber, Marco, Leone, Biagio Eugenio, Nespoli, Luca, Grasso, Marco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2995778/ https://www.ncbi.nlm.nih.gov/pubmed/21092181 http://dx.doi.org/10.1186/1479-5876-8-122 |
Ejemplares similares
-
Efficacy and Safety of Hexaminolevulinate Fluorescence Cystoscopy in the Diagnosis of Bladder Cancer
por: Lee, Jae Seung, et al.
Publicado: (2012) -
Hexaminolevulinate Blue-Light Cystoscopy in a Patient with Metastatic Melanoma of the Bladder
por: Shukla, Anant, et al.
Publicado: (2016) -
The Impact of Blue Light Cystoscopy with Hexaminolevulinate (HAL) on Progression of Bladder Cancer – A New Analysis
por: Kamat, Ashish M., et al.
Publicado: (2016) -
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
por: Lotan, Yair, et al.
Publicado: (2019) -
Evaluation of premalignant and malignant lesions by fluorescent light (VELscope)
por: Sawan, Dania, et al.
Publicado: (2015)